Citizens National Bank Trust Department grew its stake in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 16.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,044 shares of the social networking company’s stock after buying an additional 854 shares during the period. Citizens National Bank Trust Department’s holdings in Meta Platforms were worth $4,461,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of META. Inlight Wealth Management LLC acquired a new stake in Meta Platforms during the 1st quarter worth $25,000. Barnes Dennig Private Wealth Management LLC acquired a new stake in shares of Meta Platforms in the 1st quarter worth $28,000. MJT & Associates Financial Advisory Group Inc. acquired a new stake in shares of Meta Platforms in the 1st quarter worth $33,000. Evergreen Private Wealth LLC increased its holdings in shares of Meta Platforms by 237.5% in the 2nd quarter. Evergreen Private Wealth LLC now owns 54 shares of the social networking company’s stock valued at $40,000 after purchasing an additional 38 shares in the last quarter. Finally, JCIC Asset Management Inc. increased its holdings in shares of Meta Platforms by 102.6% in the 1st quarter. JCIC Asset Management Inc. now owns 79 shares of the social networking company’s stock valued at $46,000 after purchasing an additional 40 shares in the last quarter. Institutional investors and hedge funds own 79.91% of the company’s stock.
Meta Platforms Price Performance
Meta Platforms stock opened at $717.55 on Thursday. The firm’s 50-day moving average is $748.80 and its two-hundred day moving average is $681.19. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.97 and a quick ratio of 1.97. Meta Platforms, Inc. has a 12-month low of $479.80 and a 12-month high of $796.25. The stock has a market capitalization of $1.80 trillion, a P/E ratio of 25.98, a P/E/G ratio of 1.48 and a beta of 1.20.
Meta Platforms Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, September 29th. Stockholders of record on Monday, September 22nd were paid a dividend of $0.525 per share. The ex-dividend date was Monday, September 22nd. This represents a $2.10 dividend on an annualized basis and a dividend yield of 0.3%. Meta Platforms’s dividend payout ratio (DPR) is currently 7.60%.
Insider Activity
In other Meta Platforms news, COO Javier Olivan sold 517 shares of the business’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $713.34, for a total transaction of $368,796.78. Following the completion of the sale, the chief operating officer owned 8,992 shares in the company, valued at $6,414,353.28. The trade was a 5.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Robert M. Kimmitt sold 465 shares of the business’s stock in a transaction on Monday, September 15th. The shares were sold at an average price of $757.47, for a total transaction of $352,223.55. Following the sale, the director owned 8,412 shares of the company’s stock, valued at approximately $6,371,837.64. The trade was a 5.24% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 213,198 shares of company stock worth $164,232,558 over the last 90 days. Company insiders own 13.61% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on META. DA Davidson increased their price target on shares of Meta Platforms from $650.00 to $825.00 and gave the company a “buy” rating in a report on Thursday, July 31st. Royal Bank Of Canada increased their price target on shares of Meta Platforms from $740.00 to $840.00 and gave the company an “outperform” rating in a report on Thursday, July 31st. Raymond James Financial increased their price target on shares of Meta Platforms from $750.00 to $900.00 and gave the company a “strong-buy” rating in a report on Thursday, July 31st. Roth Capital increased their price target on shares of Meta Platforms from $620.00 to $740.00 and gave the company a “buy” rating in a report on Tuesday, July 8th. Finally, HSBC upgraded shares of Meta Platforms from a “hold” rating to a “buy” rating and increased their price target for the company from $610.00 to $900.00 in a report on Thursday, July 31st. Four equities research analysts have rated the stock with a Strong Buy rating, thirty-nine have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $830.68.
View Our Latest Stock Analysis on META
Meta Platforms Company Profile
Meta Platforms, Inc engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately.
Further Reading
- Five stocks we like better than Meta Platforms
- Investing in Commodities: What Are They? How to Invest in Them
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Stock Dividend Cuts Happen Are You Ready?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- What Does a Stock Split Mean?
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Meta Platforms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Meta Platforms and related companies with MarketBeat.com's FREE daily email newsletter.